Dupilumab reduces severe asthma exacerbations
J Pediatr
.
2022 Jun:245:246-249.
doi: 10.1016/j.jpeds.2022.02.039.
Author
Michael Wechsler
1
Affiliation
1
National Jewish Health, Denver, Colorado.
PMID:
35718376
DOI:
10.1016/j.jpeds.2022.02.039
No abstract available
Publication types
Comment
MeSH terms
Anti-Asthmatic Agents* / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Asthma* / drug therapy
Humans
Substances
Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
dupilumab